Nity they have cancer). Felt normative stigma also has implications for local HIV clinical trial implementation because there is a great deal of fear among PLWHA surrounding how to protect the confidentiality of their HIV status from the community. Using a mobile van to conduct clinical trials engendered several concerns relating to how PLWHA, who might benefit from clinical trials, do so without their community finding out they are HIV positive. The next stage of this research will tackle the feasibility of mobile vans or stand-alone clinics as possible mechanisms to conduct HIV clinical trials in rural settings. While the existing theoretical constructs were useful to classify some of our HIV stigma themes, we could not use this approach with all of our stigma-related themes, particularly the themes that arose from asking the questions about community/personal views on HIV/ AIDS and the difficulties of implementing HIV clinical trials locally. For the themes elicited from the community/personal views on HIV/AIDS, we classified the majority as causes of HIV stigma because we felt that T0901317 biological activity issues relating to lack of HIV/AIDS education, or denial that HIV is a problem, do not represent HIV stigma examples by themselves, but have been shown to be associated with HIV stigma.14,15 We hypothesized, however, that people not getting HIV testing could be a consequence of HIV stigma. Similarly, lack of disclosure to the community, family, or friends, or the issues of confidentiality relating to HIV clinical trials participation were classified as consequences given that these themes do not, by themselves, represent HIV stigma. It is important to address these confidentiality concernsN C Med J. Author manuscript; available in PMC 2011 February 11.Sengupta et al.Pageas a component of any intervention that we develop since they have implications for the willingness of PLWHA to participate in local HIV clinical trials, and broader implications for the elimination of health care disparities in HIV care access. Lastly, the ultimate goal in our project is to develop a mechanism (e.g., mobile van) for conducting HIV clinical trials in local, rural communities. To overcome the issue of possible breaches in confidentiality, both PLWHA and focus group participants advocated going to great lengths to hide or mask clinical trials with other types of services. Thus, if we were to take this recommendation, we could offer a combination of health care services, including HIV clinical trials, on a mobile unit or within a stand-alone clinic, as a means to protect confidentiality of individuals who are seeking HIV clinical trial services. The purposeful masking of HIV services could be a potential problem from a research ethics standpoint, but we would adhere to the principles underlying research integrity and ethics to make implementing local HIV clinical trials a viable option. As with all CPI-455 supplier studies, this study has its limitations. While we were interested in determining if there were racial/ethnic differences in the feasibility of conducting HIV clinical trials in rural communities, the textual data from the Latino participants (either from one focus group or the four individual interviews) did not suggest any relationships between HIV stigma and HIV clinical trials. Rather, other barriers to HIV clinical participation for Latino PLWHA were elicited that included being undocumented immigrants and separated from their families, dual issues that generally can affect acc.Nity they have cancer). Felt normative stigma also has implications for local HIV clinical trial implementation because there is a great deal of fear among PLWHA surrounding how to protect the confidentiality of their HIV status from the community. Using a mobile van to conduct clinical trials engendered several concerns relating to how PLWHA, who might benefit from clinical trials, do so without their community finding out they are HIV positive. The next stage of this research will tackle the feasibility of mobile vans or stand-alone clinics as possible mechanisms to conduct HIV clinical trials in rural settings. While the existing theoretical constructs were useful to classify some of our HIV stigma themes, we could not use this approach with all of our stigma-related themes, particularly the themes that arose from asking the questions about community/personal views on HIV/ AIDS and the difficulties of implementing HIV clinical trials locally. For the themes elicited from the community/personal views on HIV/AIDS, we classified the majority as causes of HIV stigma because we felt that issues relating to lack of HIV/AIDS education, or denial that HIV is a problem, do not represent HIV stigma examples by themselves, but have been shown to be associated with HIV stigma.14,15 We hypothesized, however, that people not getting HIV testing could be a consequence of HIV stigma. Similarly, lack of disclosure to the community, family, or friends, or the issues of confidentiality relating to HIV clinical trials participation were classified as consequences given that these themes do not, by themselves, represent HIV stigma. It is important to address these confidentiality concernsN C Med J. Author manuscript; available in PMC 2011 February 11.Sengupta et al.Pageas a component of any intervention that we develop since they have implications for the willingness of PLWHA to participate in local HIV clinical trials, and broader implications for the elimination of health care disparities in HIV care access. Lastly, the ultimate goal in our project is to develop a mechanism (e.g., mobile van) for conducting HIV clinical trials in local, rural communities. To overcome the issue of possible breaches in confidentiality, both PLWHA and focus group participants advocated going to great lengths to hide or mask clinical trials with other types of services. Thus, if we were to take this recommendation, we could offer a combination of health care services, including HIV clinical trials, on a mobile unit or within a stand-alone clinic, as a means to protect confidentiality of individuals who are seeking HIV clinical trial services. The purposeful masking of HIV services could be a potential problem from a research ethics standpoint, but we would adhere to the principles underlying research integrity and ethics to make implementing local HIV clinical trials a viable option. As with all studies, this study has its limitations. While we were interested in determining if there were racial/ethnic differences in the feasibility of conducting HIV clinical trials in rural communities, the textual data from the Latino participants (either from one focus group or the four individual interviews) did not suggest any relationships between HIV stigma and HIV clinical trials. Rather, other barriers to HIV clinical participation for Latino PLWHA were elicited that included being undocumented immigrants and separated from their families, dual issues that generally can affect acc.